ORCL stock | POC | Value Area | VAH | VAL

 

ORCL stock | The latest options trading activity for tomorrow

 

Options activity for Oracle (ORCL) shows a heavy burst of volume, with over 502,170 contracts traded as the stock hovers near $130 following its recent pullback. [1, 2]

The options market is flashing a surprisingly bullish near-term bias, even as the equity faces immediate downward pressure. [1]

---

1. Monitor Key Trading Volume Metrics

• Put-Call Ratio: The overall volume put-call ratio sits at 0.38. This indicates that call options (bullish bets) are heavily outnumbering put options (bearish bets). [1, 2, 3, 4, 5]
• Open Interest: Outstanding positions have spiked to 2.73 million contracts. This is nearly 110% higher than the 30-day average, signaling intense positioning for a near-term move. [1]
• Implied Volatility (IV): IV is currently resting at 59.11% (placing it in the 51st percentile). This reflects an elevated, yet stable premium pricing environment—options are not excessively overpriced despite the stock's steep drop. [1, 2, 3]

---

2. Identify Significant Blocks & Strike Heatmaps

Institutional flow and retail volume are clustering around specific target levels:

Expiration Date	Option Type	Strike Price	Key Activity / Notable Flow
July 17, 2026 (This Friday)	Call	$100.00	Strong deep In-The-Money (ITM) support building with rising open interest.
July 24, 2026	Call & Put	At-The-Money	A massive single-day block of 10,900 calls and 10,900 puts was opened. This indicates a large institutional straddle—a bet on massive volatility without directional bias.
July 31, 2026	Call	$140.00	10,000 contracts were aggressively bought in a single transaction when the stock dipped, targeting a fast rebound to the $140 level.

---

3. Gauge What This Means for Tomorrow

The heavily skewed 0.38 put-call ratio suggests that traders are actively using the drop below the historical $134 support floor to buy cheap, longer-dated upside calls rather than loading up on immediate downside puts. [1, 2]

However, the presence of the July 24 straddle warns that large funds are bracing for an explosive breakout or breakdown within the next week. [1]

---

If you want to map out how this might impact your position, tell me:

• Are you looking to protect an existing long stock position?
• Do you want to see the exact premium pricing for specific strikes?
• Are you considering an implied volatility strategy like a straddle or spread?

Let me know what you'd like to calculate next!

AI responses may include mistakes. For financial advice, consult a professional. Learn more

Oracle(ORCL) Stock Options Chain | Quotes & News - Moomoo

Orcl stock have not bottomed yet, low lower case analysis? technical analysis under EMA 200 will have concern about Gamma issues related to market distributor?

 Oracle stock has undeniably faced steep downward pressure, shedding over 40% from its recent highs to trade in the low $130 range, officially testing critical 52-week support. [1, 2]

Here is a breakdown of the technicals, market forces, and structural concerns:

1. Technical Analysis: Below the EMA 200

• Oversold Status: Oracle's 14-day RSI recently dropped into deeply oversold territory, signaling that the momentum of the sell-off has been historically severe. [1]
• EMA 200 Breakdown: The stock is currently trading decisively below its 200-day simple moving average. In traditional technical analysis, lingering under the EMA 200 invalidates long-term bullish structures and can trigger algorithmic selling. This results in the stock being classified by many quantitative screens as a "Strong Sell" until it can establish a definitive consolidation base. [1, 2, 3, 4]

2. Market Distributor & Gamma Issues

• Liquidity and Options Market Mechanics: The concerns you mentioned regarding Gamma issues are valid during sharp tech sell-offs. When large-cap technology stocks break key support levels, it often causes a cascade in the options chain. Market makers (dealers) who are short put options or long call options must adjust their portfolios dynamically (Gamma and Delta hedging).
• The Feedback Loop: If market distributors are forced to hedge their gamma exposure as the stock drops, they are often required to sell underlying shares. This forces even more downward momentum on the equity price, further exacerbating the technical damage.

3. Structural Concerns: The CapEx and Dilution Debate

• Aggressive Spending: The stock's recent crash from its previous highs was primarily triggered by investor anxiety over the company's massive AI infrastructure capital expenditures. [1]
• Shareholder Dilution Risk: Oracle announced plans to raise up to $40 billion to finance these data center buildouts, which will likely involve fresh debt and equity issuance. Analysts have specifically warned that issuing common stock to settle convertibles or ATM programs dilutes existing shareholders and actively limits a stock's ability to "bottom" quickly. [1, 2, 3, 4, 5]
• The Bull Perspective: Despite the technical bleed, long-term bulls point to Oracle’s massive Remaining Performance Obligations (RPO) and argue that the sell-off is a mispricing caused by aggressive near-term spending. [1, 2, 3]

ORCL stock | Debt issues

 "The balance sheet makes this harder to ignore. Oracle is carrying $104 billion in debt, a debt-to-equity ratio above 5x, and free cash flow that turned negative last year after averaging $12 billion annually for nearly a decade. Across 80 large-cap tech peers, Oracle sits in the bottom 5th percentile on leverage. No other major software company has stretched its balance sheet this far while simultaneously betting on a growth inflection."

- This is where it's gone the wrong way. On 8 July, S&P cut Oracle to BBB- and the numbers behind it aren't pretty. Total debt sits around $167 billion and is still climbing. Oracle is raising capital hard to fund the buildout: a $5 billion convertible preferred in February, a $20 billion equity issuance planned this year, and tens of billions more flagged over the next three years.

"A standard DCF spits out $300 intrinsic value, implying massive upside."
"Analysts project revenue nearly doubling from $57 billion today to $130 billion by FY2028."

- The valuation math is broadly unchanged. It still runs on analyst revenue estimates, now around 30% a year, with revenue tripling to roughly $218 billion by FY2030. The difference is that the first year of that ramp actually happened, so those estimates carry more credibility than they did when I first wrote about it.

So where does that leave us? The demand is real and the backlog is enormous, but the whole thesis now rests on execution. Our DCF still says the reward is there at roughly $300 against $141 today. But that number assumes clean execution, and the S&P cut is the market reminding you that clean execution is exactly what's in doubt. Cheap for a reason, or cheap despite a fixable problem. That's the call you're actually making here.